Be Well 360, LLC

07/24/2025

07/19/2025

We need tradesmen. Don’t push your kids into debt. They sent the kids to coding classes… AI will do that. 140,000 are needed per year for just 1 company.

07/15/2025

I’m not the one, honey. Your life is that of hot s**t- just to match your insides.
Dual flames one for the face you show, and one for the face you hide: So it Is DONE.

07/14/2025

Stillness is NOT emptiness.

🤌🏼🤌🏼

07/14/2025

He remains in jail, unable to post bond.

07/12/2025

06/19/2025

Buckeye

A death involving a teenager who smoked ma*****na and later exhibited signs of an opioid overdose has led police to an illegal ma*****na and firearm sales operation based in Buckeye, […]

05/13/2025

How did you spend your night?
I woke up a million a tons lighter.
I did a lot of releasing and (unconscious) contractual dissolution.

05/01/2025

04/13/2025

02/25/2025

Dr. Beata Halassy, a Croatian virologist, used lab-grown viruses to treat her own recurring breast cancer - and she succeeded.

Dr. Halassy turned to oncolytic virotherapy (OVT), a cutting-edge approach where viruses are designed to attack cancer cells and trigger the immune system to respond. While OVT is approved for certain cancers like metastatic melanoma, it hadn’t been explored for breast cancer. So, she decided to take matters into her own hands, injecting a mix of lab-grown measles and vesicular stomatitis viruses directly into her tumor.

Over two months, the tumor shrank and detached from surrounding tissue, paving the way for successful surgical removal. Four years later, she remains cancer-free.

Her bold decision has sparked both awe and controversy. On one hand, her case shines a light on the untapped potential of experimental treatments that could redefine how we approach cancer. On the other, it raises ethical questions about self-experimentation and the risks involved.

Many scientific journals initially rejected her work, fearing it might encourage others to take unsafe medical risks. But in 2024, her findings were finally published, opening a conversation about innovation, ethics, and the role of personalized medicine.

Dr. Halassy’s story isn’t just about fighting cancer; it’s about challenging the boundaries of what’s possible and pushing the conversation forward.